These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 27997036)
1. Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies. Marquié M; Normandin MD; Meltzer AC; Siao Tick Chong M; Andrea NV; Antón-Fernández A; Klunk WE; Mathis CA; Ikonomovic MD; Debnath M; Bien EA; Vanderburg CR; Costantino I; Makaretz S; DeVos SL; Oakley DH; Gomperts SN; Growdon JH; Domoto-Reilly K; Lucente D; Dickerson BC; Frosch MP; Hyman BT; Johnson KA; Gómez-Isla T Ann Neurol; 2017 Jan; 81(1):117-128. PubMed ID: 27997036 [TBL] [Abstract][Full Text] [Related]
2. Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Marquié M; Normandin MD; Vanderburg CR; Costantino IM; Bien EA; Rycyna LG; Klunk WE; Mathis CA; Ikonomovic MD; Debnath ML; Vasdev N; Dickerson BC; Gomperts SN; Growdon JH; Johnson KA; Frosch MP; Hyman BT; Gómez-Isla T Ann Neurol; 2015 Nov; 78(5):787-800. PubMed ID: 26344059 [TBL] [Abstract][Full Text] [Related]
3. [ Marquié M; Agüero C; Amaral AC; Villarejo-Galende A; Ramanan P; Chong MST; Sáez-Calveras N; Bennett RE; Verwer EE; Kim SJW; Dhaynaut M; Alvarez VE; Johnson KA; McKee AC; Frosch MP; Gómez-Isla T Acta Neuropathol Commun; 2019 Oct; 7(1):164. PubMed ID: 31661038 [TBL] [Abstract][Full Text] [Related]
4. 18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy. Passamonti L; Vázquez Rodríguez P; Hong YT; Allinson KS; Williamson D; Borchert RJ; Sami S; Cope TE; Bevan-Jones WR; Jones PS; Arnold R; Surendranathan A; Mak E; Su L; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB Brain; 2017 Mar; 140(3):781-791. PubMed ID: 28122879 [TBL] [Abstract][Full Text] [Related]
5. Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case. Marquié M; Verwer EE; Meltzer AC; Kim SJW; Agüero C; Gonzalez J; Makaretz SJ; Siao Tick Chong M; Ramanan P; Amaral AC; Normandin MD; Vanderburg CR; Gomperts SN; Johnson KA; Frosch MP; Gómez-Isla T Acta Neuropathol Commun; 2017 Oct; 5(1):75. PubMed ID: 29047416 [TBL] [Abstract][Full Text] [Related]
6. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies. Ono M; Sahara N; Kumata K; Ji B; Ni R; Koga S; Dickson DW; Trojanowski JQ; Lee VM; Yoshida M; Hozumi I; Yoshiyama Y; van Swieten JC; Nordberg A; Suhara T; Zhang MR; Higuchi M Brain; 2017 Mar; 140(3):764-780. PubMed ID: 28087578 [TBL] [Abstract][Full Text] [Related]
7. An autoradiographic evaluation of AV-1451 Tau PET in dementia. Lowe VJ; Curran G; Fang P; Liesinger AM; Josephs KA; Parisi JE; Kantarci K; Boeve BF; Pandey MK; Bruinsma T; Knopman DS; Jones DT; Petrucelli L; Cook CN; Graff-Radford NR; Dickson DW; Petersen RC; Jack CR; Murray ME Acta Neuropathol Commun; 2016 Jun; 4(1):58. PubMed ID: 27296779 [TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography imaging of tau pathology in progressive supranuclear palsy. Coakeley S; Cho SS; Koshimori Y; Rusjan P; Harris M; Ghadery C; Kim J; Lang AE; Wilson A; Houle S; Strafella AP J Cereb Blood Flow Metab; 2017 Sep; 37(9):3150-3160. PubMed ID: 28155586 [TBL] [Abstract][Full Text] [Related]
9. Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue. Aguero C; Dhaynaut M; Normandin MD; Amaral AC; Guehl NJ; Neelamegam R; Marquie M; Johnson KA; El Fakhri G; Frosch MP; Gomez-Isla T Acta Neuropathol Commun; 2019 Mar; 7(1):37. PubMed ID: 30857558 [TBL] [Abstract][Full Text] [Related]